Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

BDNF as a Promising Therapeutic Agent in Parkinson’s Disease
Ewelina Pałasz, Adrianna Wysocka, Anna Gąsiorowska, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 3, pp. 1170-1170
Open Access | Times Cited: 382

Showing 1-25 of 382 citing articles:

The Biology and Pathobiology of Glutamatergic, Cholinergic, and Dopaminergic Signaling in the Aging Brain
Anna Gąsiorowska, Małgorzata Wydrych, Patrycja Drapich, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 114
Brain-derived neurotrophic factor and inflammation in depression: Pathogenic partners in crime?
Grace A. Porter, Jason C. O’Connor
World Journal of Psychiatry (2022) Vol. 12, Iss. 1, pp. 77-97
Open Access | Times Cited: 108
Mitochondria, energy, and metabolism in neuronal health and disease
Diogo Trigo, Catarina Avelar, Miguel X. Fernandes, et al.
FEBS Letters (2022) Vol. 596, Iss. 9, pp. 1095-1110
Closed Access | Times Cited: 106
Copper Induces Cognitive Impairment in Mice via Modulation of Cuproptosis and CREB Signaling
Ying Zhang, Qian Zhou, Lu Lu, et al.
Nutrients (2023) Vol. 15, Iss. 4, pp. 972-972
Open Access | Times Cited: 74
GAP-43 and BASP1 in Axon Regeneration: Implications for the Treatment of Neurodegenerative Diseases
Daayun Chung, Andrew Shum, Gabriela Caraveo
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 133
The Relation of the Brain-Derived Neurotrophic Factor with MicroRNAs in Neurodegenerative Diseases and Ischemic Stroke
Ceren Eyileten, Lucia Sharif, Zofia Wicik, et al.
Molecular Neurobiology (2020) Vol. 58, Iss. 1, pp. 329-347
Open Access | Times Cited: 109
The emerging role of the BDNF-TrkB signaling pathway in the modulation of pain perception
Natalia Cappoli, Elisabetta Tabolacci, Paola Aceto, et al.
Journal of Neuroimmunology (2020) Vol. 349, pp. 577406-577406
Closed Access | Times Cited: 97
Alpha-Synuclein as a Biomarker of Parkinson’s Disease: Good, but Not Good Enough
Upasana Ganguly, Sukhpal Singh, Soumya Pal, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 95
Multiple Roles in Neuroprotection for the Exercise Derived Myokine Irisin
Mohammad Jodeiri Farshbaf, Karina Alviña
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 80
Baicalein alleviates depression-like behavior in rotenone- induced Parkinson's disease model in mice through activating the BDNF/TrkB/CREB pathway
Xiaoyue Zhao, Dewen Kong, Qimeng Zhou, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 140, pp. 111556-111556
Open Access | Times Cited: 73
Molecular Mechanisms Underlying the Beneficial Effects of Exercise on Brain Function and Neurological Disorders
Kévin Nay, William J. Smiles, Jacqueline Kaiser, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 4052-4052
Open Access | Times Cited: 65
Myokines and Resistance Training: A Narrative Review
Beate E. M. Zunner, Nadine Wachsmuth, Max L. Eckstein, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3501-3501
Open Access | Times Cited: 64
Incretin and insulin signaling as novel therapeutic targets for Alzheimer’s and Parkinson’s disease
Joseph Nowell, Eleanor G Blunt, Paul Edison
Molecular Psychiatry (2022) Vol. 28, Iss. 1, pp. 217-229
Open Access | Times Cited: 63
Emerging role of mesenchymal stromal cells (MSCs)-derived exosome in neurodegeneration-associated conditions: a groundbreaking cell-free approach
Hadi Yari, M. V. Mikhailova, Mahsa Mardasi, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 61
Brain-Derived Neurotropic Factor in Neurodegenerative Disorders
Abdallah Mohammad Ibrahim, Lalita Chauhan, Aditi Bhardwaj, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1143-1143
Open Access | Times Cited: 55
Physical Exercise and Health: A Focus on Its Protective Role in Neurodegenerative Diseases
Roberto Bonanni, Ida Cariati, Umberto Tarantino, et al.
Journal of Functional Morphology and Kinesiology (2022) Vol. 7, Iss. 2, pp. 38-38
Open Access | Times Cited: 54
Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease
Ahsas Goyal, Aanchal Verma, Nandini Dubey, et al.
Journal of Food Biochemistry (2022) Vol. 46, Iss. 12
Closed Access | Times Cited: 47
Neuroprotective Effects of Bifidobacterium breve CCFM1067 in MPTP-Induced Mouse Models of Parkinson’s Disease
Tiantian Li, Chuanqi Chu, Leilei Yu, et al.
Nutrients (2022) Vol. 14, Iss. 21, pp. 4678-4678
Open Access | Times Cited: 46
The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment
Angelica Varesi, Lucrezia Irene Maria Campagnoli, Foroogh Fahmideh, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12289-12289
Open Access | Times Cited: 45
Delivering the Promise of Gene Therapy with Nanomedicines in Treating Central Nervous System Diseases
Meihua Luo, Leo Kit Cheung Lee, Bo Peng, et al.
Advanced Science (2022) Vol. 9, Iss. 26
Open Access | Times Cited: 43
Liquid crystalline lipid nanoparticles for combined delivery of curcumin, fish oil and BDNF: In vitro neuroprotective potential in a cellular model of tunicamycin-induced endoplasmic reticulum stress
Miora Rakotoarisoa, Borislav Angelov, Markus Drechsler, et al.
Smart Materials in Medicine (2022) Vol. 3, pp. 274-288
Open Access | Times Cited: 41
The role of Tumour Necrosis Factor in neuroinflammation associated with Parkinson's disease and targeted therapies
Ruhul Amin, Cristina Quispe, Anca Oana Docea, et al.
Neurochemistry International (2022) Vol. 158, pp. 105376-105376
Closed Access | Times Cited: 39
BDNF Therapeutic Mechanisms in Neuropsychiatric Disorders
Amjad H. Bazzari, Firas H. Bazzari
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8417-8417
Open Access | Times Cited: 38
Oral administration of silybin protects against MPTP-induced neurotoxicity by reducing pro-inflammatory cytokines and preserving BDNF levels in mice
Ricardo Jair Ramírez‐Carreto, Víctor J. Zaldívar-Machorro, Dafne J. Pérez-Ramírez, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 26
Mesenchymal stromal cell-derived secretome-based therapy for neurodegenerative diseases: overview of clinical trials
Maryam Ghasemi, Elham Roshandel, Mozhdeh Mohammadian, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top